H.C. Wainwright raised the firm’s price target on Delcath Systems (DCTH) to $31 from $29 and keeps a Buy rating on the shares following the Q2 report. The firm says robust Hepzato adoption continues to drive growth.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCTH: